Mirvaso 3.3mg/g
Mirvaso 3.3mg/g is a medicine authorised by Swissmedic under authorisation number 65180. The authorisation holder is Galderma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 November 2014 and the authorisation is valid without a time limit. ATC code D11AX21 places the medicine in the group Other dermatological preparations.
| Authorisation number | 65180 |
|---|---|
| Name | Mirvaso 3.3mg/g |
| Full name | Mirvaso 3.3mg/g, Gel |
| Authorisation holder | Galderma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D11AX21 |
| First authorisation | 21 November 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mirvaso 3.3mg/g, Gel | B | 21 November 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 30 | g | D11AX21 | 10.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Mirvaso 3.3mg/g authorised in Switzerland?
Yes. Mirvaso 3.3mg/g is authorised by Swissmedic under authorisation number 65180, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mirvaso 3.3mg/g have?
Mirvaso 3.3mg/g is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mirvaso 3.3mg/g?
The authorisation holder is Galderma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.